The British firm that says it has created an erection sustaining condom has fallen out with its marketing partner, Reckitt Benckiser, forcing it to go ahead with production on its own.
Futura Medical says it was unable to find: "common ground acceptable to both parties in respect of their continued development and commercialisation of the CSD500 condom."
Surrey based Futura now says it will take control of the manufacturing process on its own while it casts around for other potential partners.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group's Chief Executive, James Barder, said: "Futura has received considerable interest in CSD500 from potential marketing partners. We are therefore confident of relicensing the product on attractive commercial terms and of creating significant value for shareholders."
The market was less than happy with the news. Futura's stock is down 19% at 11:31.
BS
-
Tesla earnings: live preview and analysisCan the electric car-maker overcome a big deliveries miss ahead of earnings?
-
Can I shield my ISAs from inheritance tax?Many investors and savers will be wondering if there’s anything they can do to protect their ISAs from inheritance tax, especially as pensions will become liable for the levy from April 2027. We reveal the options available to ISA customers
